Imbalance between nitric oxide generation and oxidative stress in patients with peripheral arterial disease: Effect of an antioxidant treatment

Journal of Vascular Surgery

Volumn 44, Issue 3, 2006, Pages 525-530

  Loffredo, Lorenzo ^a   Pignatelli, Pasquale ^a   Cangemi, Roberto ^a   Andreozzi, Paola ^a   Panico, Maria Antonietta ^b   Meloni, Valerio ^b   Violi, Francesco ^a  

^a Clinica Medica   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXY 2 DEOXYGUANOSINE; ANTIOXIDANT; BIOLOGICAL MARKER; NITRATE; NITRIC OXIDE; NITRITE; PLACEBO; PROPIONYLCARNITINE; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTERY DISEASE; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENDOTHELIUM CELL; FEMALE; HUMAN; MALE; MEASUREMENT; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VASODILATATION; WALKING;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTERIAL OCCLUSIVE DISEASES; CARNITINE; CROSS-SECTIONAL STUDIES; DEOXYGUANOSINE; FEMALE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; OXIDATIVE STRESS;

EID: 33747885680     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2006.05.023     Document Type: Article

References (22)

1. Criqui M.H., and Denenberg J.O. The generalized nature of atherosclerosis. how peripheral arterial disease may predict adverse events from coronary artery disease. Vasc Med 3 (1998) 241-245
2. Dormandy J., Mahir M., Ascady G., Balsano F., De Leeuw P., Blombery P., et al. Fate of the patient with chronic leg ischaemia. A review article. J Cardiovasc Surg (Torino) 30 (1989) 50-57
3. Barbato J.E., and Tzeng E. Nitric oxide and arterial disease. J Vasc Surg 40 (2004) 187-193
4. Hayashi T., Juliet P.A., Matsui-Hirai H., Miyazaki A., Fukatsu A., Funami J., et al. L-Citrulline and L-arginine supplementation retards the progression of high-cholesterol-diet-induced atherosclerosis in rabbits. Proc Natl Acad Sci U S A 102 (2005) 13681-13686
5. Boger R.H., Bode-Boger S.M., Thiele W., Junker W., Alexander K., and Frolich J.C. Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation 95 (1997) 2068-2074
6. Cooke J.P. Flow, NO, and atherogenesis. Proc Natl Acad Sci U S A 100 (2003) 768-770
7. Mueller T., Dieplinger B., Gegenhuber A., Haidinger D., Schmid N., Roth N., et al. Serum total 8-iso-prostaglandin F2alpha. a new and independent predictor of peripheral arterial disease. J Vasc Surg 40 (2004) 768-773
8. Monaco C., Crea F., Niccoli G., Summaria F., Cianflone D., Bordone R., et al. Autoantibodies against oxidized low density lipoproteins in patients with stable angina, unstable angina or peripheral vascular disease; pathophysiological implications. Eur Heart J 22 (2001) 1572-1577
9. Pignatelli P., Lenti L., Sanguigni V., Frati G., Simeoni I., Gazzaniga P.P., et al. Carnitine inhibits arachidonic acid turnover, platelet function, and oxidative stress. Am J Physiol Heart Circ Physiol 284 (2003) H41-H48
10. Hiatt W.R., Regensteiner J.G., Creager M.A., Hirsch A.T., Cooke J.P., Olin J.W., et al. Propionyl-L-carnitine improves exercise performance and functional status in patients with claudication. Am J Med 110 (2001) 616-622
11. Verdon C.P., Burton B.A., and Prior R.L. Sample pretreatment with nitrate reductase and glucose-6-phosphate dehydrogenase quantitatively reduces nitrate while avoiding interference by NADP+ when the Griess reaction is used to assay for nitrite. Anal Biochem 224 (1995) 502-508
12. Langlois M., Duprez D., Delanghe J., De Buyzere M., and Clement D.L. Serum vitamin C concentration is low in peripheral arterial disease and is associated with inflammation and severity of atherosclerosis. Circulation 103 (2001) 1863-1868
13. Bergmark C., Wu R., de Faire U., Lefvert A.K., and Swedenborg J. Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL. Arterioscler Thromb Vasc Biol 15 (1995) 441-445
14. Mancinelli A., Longo A., Nation R.L., and Evans A.M. Disposition of L-carnitine and its short-chain esters, acetyl-L-carnitine and propionyl-L-carnitine, in the rat isolated perfused liver. Drug Metab Dispos 28 (2000) 1401-1404
15. Harper P., Elwin C.E., and Cederblad G. Pharmacokinetics of bolus intravenous and oral doses of L-carnitine in healthy subjects. Eur J Clin Pharmacol 35 (1988) 69-75
16. Sahajwalla C.G., Helton E.D., Purich E.D., Hoppel C.L., and Cabana B.E. Multiple-dose pharmacokinetics and bioequivalence of L-carnitine 330-mg tablet versus 1-g chewable tablet versus enteral solution in healthy adult male volunteers. J Pharm Sci 84 (1995) 627-633
17. Ruano J., Lopez-Miranda J., Fuentes F., Moreno J.A., Bellido C., Perez-Martinez P., et al. Phenolic content of virgin olive oil improves ischemic reactive hyperemia in hypercholesterolemic patients. J Am Coll Cardiol 46 (2005) 1864-1868
18. Ishibashi T., Yoshida J., and Nishio M. Evaluation of NOx in the cardiovascular system. relationship to NO-related compounds in vivo. Jpn J Pharmacol 81 (1999) 317-323
19. Nathan C. Nitric oxide as a secretory product of mammalian cells. Faseb J 6 (1992) 3051-3064
20. Maxwell A.J., Schauble E., Bernstein D., and Cooke J.P. Limb blood flow during exercise is dependent on nitric oxide. Circulation 98 (1998) 369-374
21. Boger R.H., Bode-Boger S.M., Thiele W., Creutzig A., Alexander K., and Frolich J.C. Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease. J Am Coll Cardiol 32 (1998) 1336-1344
22. Maxwell A.J., Anderson B.E., and Cooke J.P. Nutritional therapy for peripheral arterial disease. a double-blind, placebo-controlled, randomized trial of HeartBar. Vasc Med 5 (2000) 11-19